Prenetics Competitors

PRE Stock  USD 5.99  0.08  1.35%   
Prenetics Global competes with Neogen, Qiagen NV, Olink Holding, Aclaris Therapeutics, and Fonar; as well as few others. The company runs under Insurance sector within Financials industry. Analyzing Prenetics Global competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Prenetics Global to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Prenetics Global Correlation with its peers.
For information on how to trade Prenetics Stock refer to our How to Trade Prenetics Stock guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Prenetics Global competition on your existing holdings.
  
As of June 2, 2024, Return On Tangible Assets is expected to decline to -0.31. The current year's Return On Capital Employed is expected to grow to -0.23. At present, Prenetics Global's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 13.2 M, whereas Other Assets are forecasted to decline to about 6.7 M.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prenetics Global's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.306.0613.46
Details
Intrinsic
Valuation
LowRealHigh
0.295.7113.11
Details
Naive
Forecast
LowNextHigh
0.125.8113.21
Details
1 Analysts
Consensus
LowTargetHigh
5.676.236.92
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Prenetics Global. Your research has to be compared to or analyzed against Prenetics Global's peers to derive any actionable benefits. When done correctly, Prenetics Global's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Prenetics Global.

Prenetics Global Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Prenetics Global and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Prenetics and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Prenetics Global does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
FONRNEOG
BDSXQGEN
OLKQGEN
MDXHBDSX
MDXHNEOG
CSTLBDSX
  
High negative correlations   
BDSXSERA
SERAQGEN
BNROLK
SERAOLK
CSTLFONR
SERANEOG

Risk-Adjusted Indicators

There is a big difference between Prenetics Stock performing well and Prenetics Global Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prenetics Global's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NEOG  1.85 (0.44) 0.00 (0.22) 0.00 
 3.24 
 12.56 
QGEN  0.93 (0.04)(0.03) 0.00  1.18 
 1.63 
 6.43 
OLK  0.67  0.07  0.06  0.27  0.70 
 1.50 
 4.77 
ACRS  2.66 (0.20) 0.00 (0.13) 0.00 
 4.44 
 22.34 
FONR  2.03 (0.60) 0.00 (0.50) 0.00 
 4.14 
 13.55 
BNR  2.98 (0.19) 0.00 (0.12) 0.00 
 6.07 
 29.24 
SERA  3.39  0.17  0.02 (0.29) 4.83 
 5.54 
 29.16 
BDSX  2.54 (0.11) 0.00 (0.03) 0.00 
 5.93 
 16.18 
CSTL  2.79 (0.03) 0.00  0.02  5.11 
 5.85 
 25.95 
MDXH  2.88 (0.36) 0.00  1.29  0.00 
 6.80 
 21.27 

Cross Equities Net Income Analysis

Compare Prenetics Global and related stocks such as Neogen, Qiagen NV, and Olink Holding AB Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
NEOG(1.1 M)22.5 M27.2 M28.2 M33.5 M36.6 M43.8 M63.1 M60.2 M59.5 M60.9 M48.3 M(22.9 M)(26.3 M)(25 M)
QGEN2.4 M96 M129.5 M69.1 M116.6 M127.1 M80.4 M40.4 M190.4 M(41.5 M)73.6 M512.6 M423.2 M341.3 M358.4 M
OLK(17.9 M)(17.9 M)(17.9 M)(17.9 M)(17.9 M)(17.9 M)(17.9 M)(17.9 M)(17.9 M)(17.9 M)(6.8 M)(38.3 M)(12.9 M)(31.7 M)(33.2 M)
ACRS(5.2 M)(5.2 M)(5.2 M)(5.2 M)(8.5 M)(20.6 M)(48.1 M)(68.5 M)(132.7 M)(142.8 M)(51.2 M)(114.3 M)(88.7 M)(88.5 M)(92.9 M)
FONR(7.5 M)5.8 M8.7 M10.4 M12.9 M15.7 M19.6 M21.2 M20.5 M11.7 M13.7 M17.2 M9.4 M10.8 M11.3 M
BNR(131.3 M)(131.3 M)(131.3 M)(131.3 M)(131.3 M)(131.3 M)(131.3 M)(131.3 M)(177.5 M)(168.3 M)(373.7 M)(796.7 M)(971.2 M)(653.7 M)(686.4 M)
SERA(20.4 M)(20.4 M)(20.4 M)(20.4 M)(20.4 M)(20.4 M)(20.4 M)(20.4 M)(20.4 M)(20.4 M)(21.6 M)(36.2 M)(44.2 M)(36.2 M)(38.1 M)
BDSX(26.2 M)(26.2 M)(26.2 M)(26.2 M)(26.2 M)(26.2 M)(26.2 M)(26.2 M)(26.2 M)(31.4 M)(36.5 M)(44.5 M)(80.4 M)(52.1 M)(54.8 M)
CSTL(12.4 M)(12.4 M)(12.4 M)(12.4 M)(12.4 M)(12.4 M)(12.4 M)(12.4 M)(6.4 M)5.3 M(10.3 M)(31.3 M)(67.1 M)(57.5 M)(54.6 M)
MDXH(7 M)(9 M)(11.9 M)(16.2 M)(15.3 M)(14.5 M)(13.2 M)(12.3 M)(32.5 M)(43.1 M)(30 M)(30.9 M)(50.2 M)(43.1 M)(40.9 M)

Prenetics Global and related stocks such as Neogen, Qiagen NV, and Olink Holding AB Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Prenetics Global financial statement analysis. It represents the amount of money remaining after all of Prenetics Global operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Prenetics Global Competitive Analysis

The better you understand Prenetics Global competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Prenetics Global's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Prenetics Global's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PRE NEOG QGEN OLK ACRS FONR BNR SERA BDSX CSTL
 1.35 
 5.99 
Prenetics
 0.30 
 13.15 
Neogen
 1.45 
 43.26 
Qiagen
 0.25 
 23.95 
Olink
 1.90 
 1.03 
Aclaris
 0.19 
 15.59 
Fonar
 5.30 
 7.15 
Burning
 9.18 
 9.00 
Sera
 5.93 
 1.43 
BiodesixInc
 3.92 
 23.26 
Castle
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Prenetics Global Competition Performance Charts

Five steps to successful analysis of Prenetics Global Competition

Prenetics Global's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Prenetics Global in relation to its competition. Prenetics Global's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Prenetics Global in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Prenetics Global's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Prenetics Global, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Prenetics Global position

In addition to having Prenetics Global in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Biotech Thematic Idea Now

Biotech
Biotech Theme
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Prenetics Global is a strong investment it is important to analyze Prenetics Global's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Prenetics Global's future performance. For an informed investment choice regarding Prenetics Stock, refer to the following important reports:
Check out Prenetics Global Correlation with its peers.
For information on how to trade Prenetics Stock refer to our How to Trade Prenetics Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Prenetics Stock analysis

When running Prenetics Global's price analysis, check to measure Prenetics Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prenetics Global is operating at the current time. Most of Prenetics Global's value examination focuses on studying past and present price action to predict the probability of Prenetics Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prenetics Global's price. Additionally, you may evaluate how the addition of Prenetics Global to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is Prenetics Global's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prenetics Global. If investors know Prenetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prenetics Global listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.83)
Revenue Per Share
1.933
Quarterly Revenue Growth
(0.90)
Return On Assets
(0.12)
Return On Equity
(0.25)
The market value of Prenetics Global is measured differently than its book value, which is the value of Prenetics that is recorded on the company's balance sheet. Investors also form their own opinion of Prenetics Global's value that differs from its market value or its book value, called intrinsic value, which is Prenetics Global's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prenetics Global's market value can be influenced by many factors that don't directly affect Prenetics Global's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prenetics Global's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prenetics Global is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prenetics Global's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.